Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: GlobalData
Provider: New Constructs, LLC
Provider: Directors Deals Ltd.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valeant Pharmaceuticals International updates on FY 2014 revenue guidance - Conference Call

Wednesday, 28 May 2014 04:00pm EDT 

Valeant Pharmaceuticals International Inc:Says it will be closer to $9 bln revenue for FY 2014.FY 2014 revenue of $8.5 bln - Thomson Reuters I/B/E/S. 

Company Quote

-0.22 -0.16%
24 Dec 2014